Addenbrooke's Hospital
Research and Development
The Rosie Hospital
Commercial research
Innovation and excellence in health and care
The information on this page applies to those studies sponsored and funded by pharma companies, biotech industry for commercial purposes.
Sometimes commercial organisations support work through funding or otherwise that is for public benefit. These projects do not come under commercial research remit and are considered as non-commercial research.
The Trust aims to provide R&D approval for commercially sponsored research projects within 35 days of receipt of a valid application. A valid application consists of completed:
- IRAS R&D form
- SSIF with required signatures
- Research protocol
- All regulatory approvals
- Version controlled copy of PIS and ICF
- CV’s of all investigators
- Draft mCTA and study budget for negotiation
All the above documents should be sent to: commercialtrials@addenbrookes.nhs.uk
Clinical Trials involving commercial sponsorship have slightly different requirements, mostly concerning contractual issues. If your project has a commercial sponsor, please read our commercial research policy.
Please contact the commercial trials manager (see R&D contacts) for queries and advice on accepted finance and other study related issues.
Over £10.8m to support groundbreaking clinical research in Cambridge
CUH has been awarded just over £10.8 million from the National Institute for Health Research to develop new treatments to benefit patients in the East of England.
The presentations from our EU Open Day at CUH are now available for download at the PONTE project website.
Public involvement in research group
Get involved in the design of future health and social care research at the launch of new group on 2 November 2011.
£110 million health research fund confirms elite biomedical status for CUH
Cambridge University Hospitals and the University of Cambridge have been awarded a record share of an £800 million government research fund, confirming the city’s status as one of the country’s elite Biomedical Research Centres.
